OVID
Ovid Therapeutics Inc
2.30$
-0.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -17.5% | +3,553.8% | +0.0% | -99.9% | -199,899.9% | – | -100.0% | – | +316.9% | +42.6% | +13.6% | +45.3% | +30.3% | +4.2% | +14.2% | +2.4% | -56.1% | +71.1% | +4,724.6% | -97.9% | +443.9% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.9% | +9.4% | – | – | -5.8% | +5.9% | -9.5% | -0.8% | +1.9% | -0.3% | -66.1% | +8.8% | +14.2% | – | – | -65.1% | -82.8% | +158.8% | -20.5% | -54.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -17.5% | +3,553.8% | -100.0% | – | – | – | -130.5% | – | +316.9% | +42.6% | +13.6% | +45.3% | +30.3% | +4.2% | +14.2% | +2.4% | -56.1% | +71.1% | +4,724.6% | -97.9% | +443.9% | -104.9% | – | – | |
| – | +47.9% | +683.9% | -80.6% | -2.9% | +13.8% | +26.2% | -0.2% | +10.3% | -7.5% | +22.9% | -13.9% | +27.2% | +4.4% | +20.8% | +9.6% | -1.0% | +2.6% | -0.2% | -52.7% | -36.0% | +267.4% | -56.6% | -22.8% | -14.3% | +7.2% | +19.1% | -9.3% | -11.1% | +99.5% | -2.3% | +21.0% | -37.6% | -24.6% | +12.4% | -2.9% | -9.2% | +12.2% | +69.7% | -10.9% | – | |
| – | +15.5% | -17.2% | +41.5% | -16.7% | +23.5% | +14.3% | +2.8% | -9.1% | -2.7% | +4.7% | -10.8% | +22.9% | -0.1% | +9.8% | +25.4% | +4.7% | +39.9% | +49.6% | -57.4% | +2.0% | +22.2% | +19.6% | -16.4% | -7.6% | -3.5% | +13.3% | -13.1% | -6.1% | -9.1% | +15.8% | +13.1% | -31.6% | +22.2% | -11.1% | -19.0% | +39.0% | -5.4% | +3.8% | -7.4% | – | |
| – | +30.5% | +351.5% | -70.0% | -8.5% | +17.4% | +21.6% | -1.6% | -0.2% | -0.4% | +7.1% | -5.2% | +25.9% | +3.0% | +17.5% | +14.0% | +0.8% | +17.1% | +16.6% | -55.0% | -18.4% | +125.1% | -32.6% | -19.2% | -10.4% | -4.6% | +22.4% | -4.8% | -14.8% | +51.0% | -4.2% | +17.8% | -35.2% | -19.4% | +17.4% | -10.5% | +11.5% | +2.8% | +37.2% | -7.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -108.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | +123.4% | – | – | – | – | – | – | – | +36.0% | +194.3% | +26.6% | +145,078.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -108.1% | – | – | – | – | – | – | – | – | – | – | – | – | -264.4% | – | – | – | – | – | -275.8% | – | – | |
| – | -115.6% | – | – | – | – | +84.4% | +1.3% | -26.7% | -285.5% | – | – | – | – | – | – | – | – | +193,805.8% | +194.5% | -120.0% | – | – | +469.5% | -393.6% | – | – | – | -1.4% | -100.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -109.0% | – | – | – | – | – | – | – | – | – | – | – | – | -264.4% | – | – | – | – | – | -275.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -108.1% | – | – | – | – | – | – | – | – | – | – | – | – | -259.6% | – | – | – | – | – | -284.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.